Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctiondeath effector domain binding

CASP8 CASP10

3.98e-054522GO:0035877
GeneOntologyMolecularFunctionG protein-coupled receptor kinase activity

GRK3 GRK1

1.39e-047522GO:0004703
GeneOntologyCellularComponentripoptosome

CASP8 CASP10

8.70e-056512GO:0097342
GeneOntologyCellularComponentCD95 death-inducing signaling complex

CASP8 CASP10

1.62e-048512GO:0031265
GeneOntologyCellularComponentdeath-inducing signaling complex

CASP8 CASP10

3.16e-0411512GO:0031264
DomainGPCR_kinase

GRK3 GRK1

1.52e-047512IPR000239
DomainDED_dom

CASP8 CASP10

1.52e-047512IPR001875
DomainDED

CASP8 CASP10

1.52e-047512PF01335
DomainDED

CASP8 CASP10

1.52e-047512PS50168
DomainDED

CASP8 CASP10

1.52e-047512SM00031
DomainCASPASE_HIS

CASP8 CASP10

3.96e-0411512PS01121
DomainCaspase_cys_AS

CASP8 CASP10

4.74e-0412512IPR033139
DomainCaspase_his_AS

CASP8 CASP10

4.74e-0412512IPR016129
DomainCASPASE_P10

CASP8 CASP10

4.74e-0412512PS50207
DomainCASPASE_CYS

CASP8 CASP10

4.74e-0412512PS01122
DomainPept_C14_p10

CASP8 CASP10

4.74e-0412512IPR002138
DomainCASc

CASP8 CASP10

5.59e-0413512SM00115
DomainPept_C14A

CASP8 CASP10

5.59e-0413512IPR015917
DomainPept_C14_p20

CASP8 CASP10

6.51e-0414512IPR001309
DomainCaspase-like_dom

CASP8 CASP10

6.51e-0414512IPR029030
DomainCASPASE_P20

CASP8 CASP10

6.51e-0414512PS50208
Domain-

CASP8 CASP10

6.51e-04145123.40.50.1460
DomainThioredoxin_CS

PDIA3 NME8

9.68e-0417512IPR017937
DomainTHIOREDOXIN_1

PDIA3 NME8

2.11e-0325512PS00194
DomainThioredoxin

PDIA3 NME8

3.23e-0331512PF00085
DomainRGS

GRK3 GRK1

4.11e-0335512PF00615
DomainRGS

GRK3 GRK1

4.11e-0335512SM00315
DomainRGS

GRK3 GRK1

4.34e-0336512PS50132
DomainRGS

GRK3 GRK1

5.08e-0339512IPR016137
DomainThioredoxin_domain

PDIA3 NME8

5.60e-0341512IPR013766
DomainTHIOREDOXIN_2

PDIA3 NME8

6.15e-0343512PS51352
DomainAGC-kinase_C

GRK3 GRK1

1.02e-0256512IPR000961
DomainAGC_KINASE_CTER

GRK3 GRK1

1.02e-0256512PS51285
DomainS_TK_X

GRK3 GRK1

1.02e-0256512SM00133
PathwayREACTOME_FASL_CD95L_SIGNALING

CASP8 CASP10

8.62e-055422M27710
PathwayBIOCARTA_FAS_PATHWAY

CASP8 CASP10 PRKDC

9.44e-0530423M9503
PathwayREACTOME_TRAIL_SIGNALING

CASP8 CASP10

2.40e-048422M27711
PathwayWP_FAS_LIGAND_PATHWAY_AND_STRESS_INDUCTION_OF_HEAT_SHOCK_PROTEINS

CASP8 CASP10 PRKDC

2.99e-0444423M39673
Pubmed

Death receptor recruitment of endogenous caspase-10 and apoptosis initiation in the absence of caspase-8.

CASP8 CASP10

2.19e-06252211583996
Pubmed

Partial dysferlin reconstitution by adult murine mesoangioblasts is sufficient for full functional recovery in a murine model of dysferlinopathy.

PRKDC DYSF

2.19e-06252221364666
Pubmed

Association of the CASP10 V410I variant with reduced familial breast cancer risk and interaction with the CASP8 D302H variant.

CASP8 CASP10

2.19e-06252216251207
Pubmed

Association between CASP8 and CASP10 polymorphisms and toxicity outcomes with platinum-based chemotherapy in Chinese patients with non-small cell lung cancer.

CASP8 CASP10

2.19e-06252222843554
Pubmed

Clinicopathological significance of caspase-8 and caspase-10 expression in rectal cancer.

CASP8 CASP10

2.19e-06252218716417
Pubmed

Unique and overlapping substrate specificities of caspase-8 and caspase-10.

CASP8 CASP10

2.19e-06252216186808
Pubmed

Genetic variants and haplotypes of the caspase-8 and caspase-10 genes contribute to susceptibility to cutaneous melanoma.

CASP8 CASP10

2.19e-06252218563783
Pubmed

Caspase 8 and maspin are downregulated in breast cancer cells due to CpG site promoter methylation.

SERPINB5 CASP8

2.19e-06252220132554
Pubmed

Stimulation of hair follicle stem cell proliferation through an IL-1 dependent activation of γδT-cells.

CASP8 IL1R1

2.19e-06252229199946
Pubmed

Production by EBV infection of an EBNA-positive subline from an EBNA-negative human lymphoma cell line without detectable EBV DNA.

CASP8 CASP10

2.19e-062522170210
Pubmed

Absence of T and B lymphocytes modulates dystrophic features in dysferlin deficient animal model.

PRKDC DYSF

2.19e-06252222465227
Pubmed

Human initiator caspases trigger apoptotic and autophagic phenotypes in Saccharomyces cerevisiae.

CASP8 CASP10

2.19e-06252219166881
Pubmed

Caspase-10 Negatively Regulates Caspase-8-Mediated Cell Death, Switching the Response to CD95L in Favor of NF-κB Activation and Cell Survival.

CASP8 CASP10

2.19e-06252228445729
Pubmed

Association of polymorphisms in CASP10 and CASP8 with FEV(1)/FVC and bronchial hyperresponsiveness in ethnically diverse asthmatics.

CASP8 CASP10

6.57e-06352218823309
Pubmed

A six-nucleotide insertion-deletion polymorphism in the CASP8 promoter is associated with susceptibility to multiple cancers.

CASP8 CASP10

6.57e-06352217450141
Pubmed

Genetic variants in cell death pathway genes and HBV-related hepatocellular carcinoma among a Chinese Han population.

CASP8 CASP10

6.57e-06352228643196
Pubmed

Arthritogenic properties of double-stranded (viral) RNA.

PRKDC IL1R1

6.57e-06352215100310
Pubmed

Genetic variants in fas signaling pathway genes and risk of gastric cancer.

CASP8 CASP10

6.57e-06352223921907
Pubmed

Caspase expression in placental terminal villi in spontaneous and induced pregnancy.

CASP8 CASP10

6.57e-06352225403406
Pubmed

CASH, a novel caspase homologue with death effector domains.

CASP8 CASP10

6.57e-0635229289491
Pubmed

Glucocorticoid modulatory element-binding protein 1 binds to initiator procaspases and inhibits ischemia-induced apoptosis and neuronal injury.

GMEB1 CASP8

6.57e-06352216497673
Pubmed

Ectopic expression of the serine protease inhibitor PI9 modulates death receptor-mediated apoptosis.

CASP8 CASP10

6.57e-06352217479112
Pubmed

Mch3, a novel human apoptotic cysteine protease highly related to CPP32.

CASP8 CASP10

6.57e-0635228521391
Pubmed

Interactions of HIPPI, a molecular partner of Huntingtin interacting protein HIP1, with the specific motif present at the putative promoter sequence of the caspase-1, caspase-8 and caspase-10 genes.

CASP8 CASP10

6.57e-06352217623017
Pubmed

The death effector domain-associated factor plays distinct regulatory roles in the nucleus and cytoplasm.

CASP8 CASP10

1.31e-05452211395500
Pubmed

DEDD and DEDD2 associate with caspase-8/10 and signal cell death.

CASP8 CASP10

1.31e-05452212527898
Pubmed

Pax6 downregulation mediates abnormal lineage commitment of the ocular surface epithelium in aqueous-deficient dry eye disease.

PRKDC IL1R1

1.31e-05452224143217
Pubmed

Stoichiometry of the CD95 death-inducing signaling complex: experimental and modeling evidence for a death effector domain chain model.

CASP8 CASP10

1.31e-05452222683265
Pubmed

Caspase-10 is an initiator caspase in death receptor signaling.

CASP8 CASP10

1.31e-05452211717445
Pubmed

Caspase polymorphisms and genetic susceptibility to multiple myeloma.

CASP8 CASP10

1.31e-05452218381704
Pubmed

In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FADD-like domains.

CASP8 CASP10

1.31e-0545228755496
Pubmed

Alterations of Fas-pathway genes associated with nodal metastasis in non-small cell lung cancer.

CASP8 CASP10

1.31e-05452212037669
Pubmed

Caspase-dependent molecular mechanisms of anti-human DR5 monoclonal antibody mDRA-6 inducing apoptosis of human leukemia Jurkat cells.

CASP8 CASP10

1.31e-05452219550122
Pubmed

Genetic variants in caspase genes and susceptibility to non-Hodgkin lymphoma.

CASP8 CASP10

1.31e-05452217071630
Pubmed

Association of the variants CASP8 D302H and CASP10 V410I with breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers.

CASP8 CASP10

1.31e-05452220978178
Pubmed

Quantitative Proteomics Links the LRRC59 Interactome to mRNA Translation on the ER Membrane.

LIFR LARP4B MDN1 SSR1 PDIA3 GRAMD4

2.02e-0537552632788342
Pubmed

IDD3 and IDD5 alleles from nod mice mediate Sjögren's syndrome-like autoimmunity.

CASP8 IL1R1

2.19e-05552212614028
Pubmed

Glucocorticoid modulatory element-binding protein 1 (GMEB1) interacts with the de-ubiquitinase USP40 to stabilize CFLARL and inhibit apoptosis in human non-small cell lung cancer cells.

GMEB1 CASP8

2.19e-05552231046799
Pubmed

Identification of caspase 3-mediated cleavage and functional alteration of eukaryotic initiation factor 2alpha in apoptosis.

CASP8 CASP10

2.19e-05552210734073
Pubmed

Palmitoylation of CD95 facilitates formation of SDS-stable receptor aggregates that initiate apoptosis signaling.

CASP8 CASP10

2.19e-05552217159907
Pubmed

MyD88 is required for the formation of long-term humoral immunity to virus infection.

PRKDC IL1R1

2.19e-05552217404295
Pubmed

The biochemistry of apoptosis.

CASP8 CASP10

2.19e-05552211048727
Pubmed

Caspase-mediated cleavage of eukaryotic translation initiation factor subunit 2alpha.

CASP8 CASP10

2.19e-05552210432301
Pubmed

Polymorphisms in the CASPASE genes and survival in patients with early-stage non-small-cell lung cancer.

CASP8 CASP10

2.19e-05552219826114
Pubmed

PRMT1 promotes epigenetic reprogramming associated with acquired chemoresistance in pancreatic cancer.

PRKDC CYFIP2

2.19e-05552238691454
Pubmed

Engineered hybrid dimers: tracking the activation pathway of caspase-7.

CASP8 CASP10

2.19e-05552216916640
Pubmed

Identification of a conserved anti-apoptotic protein that modulates the mitochondrial apoptosis pathway.

CASP8 CASP10

2.19e-05552221980415
Pubmed

The importance of IL-1 beta and TNF-alpha, and the noninvolvement of IL-6, in the development of monoclonal antibody-induced arthritis.

PRKDC IL1R1

2.19e-05552212133972
Pubmed

Single nucleotide polymorphisms of matrix metalloproteinase 9 (MMP9) and tumor protein 73 (TP73) interact with Epstein-Barr virus in chronic lymphocytic leukemia: results from the European case-control study EpiLymph.

SERPINB5 SLC44A2 CASP8 CASP10 MMP12

2.49e-0523152521048031
Pubmed

Genetic variants in the candidate genes of the apoptosis pathway and susceptibility to chronic myeloid leukemia.

CASP8 CASP10 IL1R1

3.00e-054052319141860
Pubmed

The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.

CASP8 CASP10 IL1R1

3.23e-054152320959405
Pubmed

Critical role of caspase-8-mediated IL-1 signaling in promoting Th2 responses during asthma pathogenesis.

CASP8 IL1R1

3.28e-05652227007676
Pubmed

Caspase-14 is a novel developmentally regulated protease.

CASP8 CASP10

3.28e-0565229792675
Pubmed

M-CSF mediates TNF-induced inflammatory osteolysis.

PRKDC IL1R1

3.28e-05652216294221
Pubmed

Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system.

CASP8 CASP10

3.28e-0565223031469
Pubmed

Caspase-8 and caspase-10 activate NF-kappaB through RIP, NIK and IKKalpha kinases.

CASP8 CASP10

3.28e-05652212884866
Pubmed

BAR: An apoptosis regulator at the intersection of caspases and Bcl-2 family proteins.

CASP8 CASP10

3.28e-05652210716992
Pubmed

Caspase-10 is recruited to and activated at the native TRAIL and CD95 death-inducing signalling complexes in a FADD-dependent manner but can not functionally substitute caspase-8.

CASP8 CASP10

3.28e-05652212198154
Pubmed

Polymorphisms in the caspase genes and the risk of lung cancer.

CASP8 CASP10

3.28e-05652220661084
Pubmed

Apoptotic gene analysis in idiopathic talipes equinovarus (clubfoot).

CASP8 CASP10

4.58e-05752217534194
Pubmed

TRAF1 is a substrate of caspases activated during tumor necrosis factor receptor-alpha-induced apoptosis.

CASP8 CASP10

4.58e-05752211098060
Pubmed

Peroxiredoxin 6 interferes with TRAIL-induced death-inducing signaling complex formation by binding to death effector domain caspase.

CASP8 CASP10

4.58e-05752220829884
Pubmed

Members of the G protein-coupled receptor kinase family that phosphorylate the beta2-adrenergic receptor facilitate sequestration.

GRK3 GRK1

4.58e-0575228672451
Pubmed

FLAME-1, a novel FADD-like anti-apoptotic molecule that regulates Fas/TNFR1-induced apoptosis.

CASP8 CASP10

4.58e-0575229228018
Pubmed

Lipid-laden lung mesenchymal cells foster breast cancer metastasis via metabolic reprogramming of tumor cells and natural killer cells.

PRKDC IL1R1

4.58e-05752236476935
Pubmed

Functional genomic landscape of cancer-intrinsic evasion of killing by T cells.

TRAPPC11 PKNOX1 CASP8 PRKDC PDIA3 NUP160

6.08e-0545752632968282
Pubmed

The non-receptor tyrosine kinase Tec controls assembly and activity of the noncanonical caspase-8 inflammasome.

CASP8 IL1R1

6.10e-05852225474208
Pubmed

Caspase-9 can antagonize p53-induced apoptosis by generating a p76(Rb) truncated form of Rb.

CASP8 CASP10

6.10e-05852215735701
Pubmed

Induction of apoptosis by X-linked ectodermal dysplasia receptor via a caspase 8-dependent mechanism.

CASP8 CASP10

6.10e-05852215280356
Pubmed

Caspases: the executioners of apoptosis.

CASP8 CASP10

6.10e-0585229337844
Pubmed

Ubiquitination and degradation of the FADD adaptor protein regulate death receptor-mediated apoptosis and necroptosis.

CASP8 CASP10

6.10e-05852222864571
Pubmed

Protective role of Cop in Rip2/caspase-1/caspase-4-mediated HeLa cell death.

CASP8 CASP10

7.84e-05952216920334
Pubmed

Molecular ordering of the Fas-apoptotic pathway: the Fas/APO-1 protease Mch5 is a CrmA-inhibitable protease that activates multiple Ced-3/ICE-like cysteine proteases.

CASP8 CASP10

7.84e-0595228962078
Pubmed

Identification and molecular cloning of two novel receptors for the cytotoxic ligand TRAIL.

CASP8 CASP10

7.84e-0595229325248
Pubmed

Casper is a FADD- and caspase-related inducer of apoptosis.

CASP8 CASP10

7.84e-0595229208847
Pubmed

Cloning and characterization of three novel genes, ALS2CR1, ALS2CR2, and ALS2CR3, in the juvenile amyotrophic lateral sclerosis (ALS2) critical region at chromosome 2q33-q34: candidate genes for ALS2.

CASP8 CASP10

7.84e-05952211161814
Pubmed

IL-21-mediated non-canonical pathway for IL-1β production in conventional dendritic cells.

CASP8 IL1R1

7.84e-05952226269257
Pubmed

A cell-intrinsic role for TLR2-MYD88 in intestinal and breast epithelia and oncogenesis.

PRKDC IL1R1

7.84e-05952225362351
Pubmed

A missense mutation in the MLKL brace region promotes lethal neonatal inflammation and hematopoietic dysfunction.

CASP8 IL1R1

7.84e-05952232561755
Pubmed

KAP1 facilitates reinstatement of heterochromatin after DNA replication.

TRAPPC11 SUGP2 RTCA PRKDC SSR1 MTREX NUP160

8.20e-0570452729955894
Pubmed

OTULIN maintains skin homeostasis by controlling keratinocyte death and stem cell identity.

CASP8 IL1R1

9.79e-051052234625556
Pubmed

Polymorphism in tumor necrosis factor-related apoptosis-inducing ligand receptor 1 is associated with poor viral response to interferon-based hepatitis C virus therapy in HIV/hepatitis C virus-coinfected individuals.

CASP8 CASP10

9.79e-051052220802294
Pubmed

cIAPs block Ripoptosome formation, a RIP1/caspase-8 containing intracellular cell death complex differentially regulated by cFLIP isoforms.

CASP8 CASP10

9.79e-051052221737330
Pubmed

Mutational analysis of CASP1, 2, 3, 4, 5, 6, 7, 8, 9, 10, and 14 genes in gastrointestinal stromal tumors.

CASP8 CASP10

1.20e-041152219269008
Pubmed

Mutational analysis of caspase genes in prostate carcinomas.

CASP8 CASP10

1.20e-041152220402676
Pubmed

NLRP3 inflammasome plays a redundant role with caspase 8 to promote IL-1β-mediated osteomyelitis.

CASP8 IL1R1

1.20e-041152227071119
Pubmed

Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.

S100A4 SERPINB5 MDN1 SUGP2 RTCA PRKDC MTREX SMC5

1.23e-04101452832416067
Pubmed

Caspase-2 induces apoptosis by releasing proapoptotic proteins from mitochondria.

CASP8 CASP10

1.43e-041252211832478
Pubmed

Suppression of caspase-8- and -10-associated RING proteins results in sensitization to death ligands and inhibition of tumor cell growth.

CASP8 CASP10

1.43e-041252215069192
Pubmed

Genetic variation in caspase genes and risk of non-Hodgkin lymphoma: a pooled analysis of 3 population-based case-control studies.

CASP8 CASP10

1.43e-041252219414860
Pubmed

A pathway sensor for genome-wide screens of intracellular proteolytic cleavage.

CASP8 CYFIP2

1.43e-041252218387192
Pubmed

Cytoskeleton-mediated death receptor and ligand concentration in lipid rafts forms apoptosis-promoting clusters in cancer chemotherapy.

CASP8 CASP10

1.69e-041352215659383
Pubmed

Neutrophil elastase causes tissue damage that decreases host tolerance to lung infection with burkholderia species.

MMP12 IL1R1

1.69e-041352225166912
Pubmed

TNF-α Coordinates Hematopoietic Stem Cell Survival and Myeloid Regeneration.

CASP8 IL1R1

1.69e-041352231230859
Pubmed

Shotgun sequencing of the human transcriptome with ORF expressed sequence tags.

CRYBB2 SUGP2 SIDT1 MMP12 IL1R1 MPI

1.71e-0455252610737800
Pubmed

Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis.

MDN1 MGST1 CACNA1G PRKDC SPAG17 PDIA3 CYFIP2

1.90e-0480752730575818
Pubmed

Rubella vaccine-induced cellular immunity: evidence of associations with polymorphisms in the Toll-like, vitamin A and D receptors, and innate immune response genes.

CASP8 CASP10

1.97e-041452219902255
Pubmed

Interactome of the Autoimmune Risk Protein ANKRD55.

MDN1 PRKDC SSR1 NUP160

2.19e-0419752431620119
Pubmed

Activation of the NF-kappaB pathway by caspase 8 and its homologs.

CASP8 CASP10

2.27e-041552211002417
Pubmed

Identification of potential protein interactors of Lrrk2.

MDN1 PRKDC

2.27e-041552217400507
Cytoband2q33-q34

CASP8 CASP10

4.51e-0595222q33-q34
GeneFamilyCD molecules|Tumor necrosis factor receptor superfamily|Death inducing signaling complex

CASP8 CASP10

7.86e-0564221342
GeneFamilyCaspases|Death effector domain containing|Ripoptosome|Death inducing signaling complex

CASP8 CASP10

1.10e-0474221019
GeneFamilyCaspases|Caspase recruitment domain containing

CASP8 CASP10

4.04e-0413422468
CoexpressionHE_LIM_SUN_FETAL_LUNG_C5_CD5_POS_CCL22_POS_MATURE_B_CELL

S100A4 NIBAN1 LARP4B MDN1 GRK3 CCDC141 RBM47 MPI

4.67e-05666528M45778
CoexpressionGSE30083_SP1_VS_SP4_THYMOCYTE_DN

NIBAN1 IKZF3 SIDT1 PRKDC GRAMD4

4.78e-05200525M5030
CoexpressionGSE17721_CTRL_VS_PAM3CSK4_24H_BMDC_DN

NIBAN1 LARP4B MDN1 RBM47 CYFIP2

4.78e-05200525M3752
CoexpressionMANNO_MIDBRAIN_NEUROTYPES_HGABA

ANKRD44 IKZF3 MDN1 GRK3 LINGO1 SUGP2 CACNA1G SPAG17 CCDC141 CYFIP2

5.40e-0511065210M39071
CoexpressionRUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP

NIBAN1 GRK3 PKNOX1 MMP12 IL1R1 RBM47

5.71e-05341526M12636
CoexpressionBUSSLINGER_ESOPHAGEAL_DENDRITIC_CELLS

S100A4 ANKRD44 NIBAN1 GRK3 CACNA1G

6.59e-05214525M40005
CoexpressionAtlasFacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_500_k-means-cluster#5

S100A4 ANKRD44 NIBAN1 CACNA1G IL1R1 RBM47

3.45e-06172516Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_500_K5
CoexpressionAtlasFacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000_k-means-cluster#5

S100A4 ANKRD44 NIBAN1 CACNA1G IL1R1 RBM47 ANGPTL1

4.13e-06276517Facebase_RNAseq_e10.5_Olfactory Pit_1000_K5
CoexpressionAtlasalpha beta T cells, T.8Nve.PP, TCRb+ CD8+ CD44low CD62L high, Peyer's Patch, avg-1

ANKRD44 IKZF3 MDN1 SIDT1 PKNOX1 PRKDC GRAMD4

1.49e-05336517GSM538413_500
CoexpressionAtlasBM Top 100 - adrenal gland cortex

MGST1 IL1R1 RBM47 ANGPTL1

2.41e-0570514BM Top 100 - adrenal gland cortex
CoexpressionAtlasFacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000_k-means-cluster#5

S100A4 ANKRD44 NIBAN1 CACNA1G IL1R1 RBM47

2.53e-05244516Facebase_RNAseq_e9.5_Olfactory Placode_1000_K5
CoexpressionAtlasFacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_500_k-means-cluster#2

S100A4 ANKRD44 NIBAN1 CACNA1G IL1R1

2.70e-05147515Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_500_K2
CoexpressionAtlasFacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#1

S100A4 ANKRD44 NIBAN1 CACNA1G IL1R1 RBM47 ANGPTL1

2.81e-05371517Facebase_RNAseq_e9.5_Maxillary Arch_1000_K1
CoexpressionAtlasFacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_500_k-means-cluster#3

S100A4 ANKRD44 NIBAN1 CACNA1G IL1R1 ANGPTL1

2.83e-05249516Facebase_RNAseq_e8.5_Paraxial Mesoderm_500_K3
CoexpressionAtlasFacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000_k-means-cluster#1

S100A4 ANKRD44 NIBAN1 CACNA1G IL1R1 ANGPTL1

4.02e-05265516Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_1000_K1
CoexpressionAtlasMyeloid Cells, DC.103-11b+24+.Lu, MHCII+ CD11c+ CD103- CD11b+ CD24+, Lung, avg-2

S100A4 LIFR NIBAN1 GRK3 MMP12 IL1R1 RBM47

4.82e-05404517GSM854269_500
CoexpressionAtlasFacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_1000_k-means-cluster#2

S100A4 ANKRD44 NIBAN1 CACNA1G IL1R1 ANGPTL1

6.62e-05290516Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_1000_K2
CoexpressionAtlaskidney_adult_GlomCapSys_Tie2_top-relative-expression-ranked_500

S100A4 ANKRD44 LIFR SLC44A2 CASP8 IL1R1 DYSF

6.83e-05427517gudmap_kidney_adult_GlomCapSys_Tie2_500
CoexpressionAtlasFacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#4

S100A4 ANKRD44 NIBAN1 CACNA1G IL1R1 ANGPTL1

7.70e-05298516Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000_K4
CoexpressionAtlasFacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_1000_k-means-cluster#2

S100A4 ANKRD44 NIBAN1 CACNA1G IL1R1 ANGPTL1

1.35e-04330516Facebase_RNAseq_e8.5_Paraxial Mesoderm_1000_K2
CoexpressionAtlasFacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_500

S100A4 ANKRD44 NIBAN1 CACNA1G IL1R1 RBM47 CYFIP2

1.57e-04488517Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_500
CoexpressionAtlaskidney_adult_CortVasc_Tie2_top-relative-expression-ranked_1000

S100A4 LIFR SLC44A2 CASP8 SLC13A3 IL1R1 DYSF CCDC141 RBM47

1.64e-04846519gudmap_kidney_adult_CortVasc_Tie2_1000
CoexpressionAtlasFacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000_k-means-cluster#3

S100A4 NIBAN1 CASP8 CACNA1G IL1R1

2.62e-04238515Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_1000_K3
CoexpressionAtlasFacebaseRNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_1000_k-means-cluster#4

S100A4 ANKRD44 NIBAN1 CACNA1G IL1R1

2.77e-04241515Facebase_RNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_1000_K4
CoexpressionAtlasFacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_1000_k-means-cluster#3

S100A4 ANKRD44 NIBAN1 CACNA1G IL1R1 ANGPTL1

3.05e-04384516Facebase_RNAseq_e9.5_Facial Mesenchyne_1000_K3
CoexpressionAtlasFacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_500_k-means-cluster#3

S100A4 NIBAN1 IL1R1 RBM47

3.28e-04137514Facebase_RNAseq_e9.5_Maxillary Arch_500_K3
CoexpressionAtlasMyeloid Cells, Mo.6C-IIint.Bl, CD115+ B220- CD43- Ly6C- MHCIIint, Blood, avg-5

S100A4 LIFR NIBAN1 GRK3 MGST1 RBM47

3.79e-04400516GSM605886_500
CoexpressionAtlasMyeloid Cells, MF.Lv, CD45+ F4/80+ CD11b+, Liver, avg-2

S100A4 LIFR NIBAN1 GRK3 MGST1 RBM47

3.89e-04402516GSM854320_500
CoexpressionAtlasMyeloid Cells, DC.103-11b+F4/80lo.Kd, CD45+ CD11c+ I-A/I-E+ CD11b+ F4/80lo, Kidney, avg-3

S100A4 LIFR NIBAN1 GRK3 MMP12 RBM47

4.10e-04406516GSM854273_500
CoexpressionAtlasMyeloid Cells, Mo.6C+II+.Bl, CD115+ B220- CD43+ Ly6C+ MHCIIint, Blood, avg-4

S100A4 LIFR NIBAN1 GRK3 MGST1 RBM47

4.21e-04408516GSM605868_500
CoexpressionAtlasMyeloid Cells, Mo.6C+II-.Bl, Cd115+ B220- CD43+ Ly6C+ MHCII-, Blood, avg-3

S100A4 LIFR NIBAN1 GRK3 MGST1 RBM47

4.37e-04411516GSM605872_500
CoexpressionAtlaskidney_adult_GlomCapSys_Tie2_k-means-cluster#2_top-relative-expression-ranked_500

S100A4 ANKRD44 LIFR CASP8

4.50e-04149514gudmap_kidney_adult_GlomCapSys_Tie2_k2_500
CoexpressionAtlasMyeloid Cells, DC.103-11b+24-.Lu, MHCII+ CD11c+ CD103- CD11b+ CD24-, Lung, avg-2

LIFR NIBAN1 GRK3 SLC13A3 MMP12 RBM47

4.54e-04414516GSM854271_500
CoexpressionAtlasFacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000

S100A4 ANKRD44 NIBAN1 MGST1 CACNA1G IL1R1 RBM47 ANGPTL1 CYFIP2

5.00e-04984519Facebase_RNAseq_e10.5_Olfactory Pit_1000
CoexpressionAtlasFacebaseRNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#4

S100A4 ANKRD44 NIBAN1 CASP8 CACNA1G IL1R1 ANGPTL1

5.00e-04591517Facebase_RNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_2500_K4
CoexpressionAtlasMyeloid Cells, MF.Thio5.II+480lo.PC, CD115+ MHC II+ F480lo SiglecF- CD11c+, Peritoneal Cavity, avg-3

S100A4 LIFR GRK3 SLC13A3 MMP12 RBM47

5.28e-04426516GSM605859_500
CoexpressionAtlasMyeloid Cells, Mo.6C+II-.LN, F480+ Ly6c+ MHCII lo/+, Lymph Node, avg-3

S100A4 GRK3 MGST1

5.86e-0468513GSM605875_100
CoexpressionAtlasFacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_500_k-means-cluster#3

S100A4 NIBAN1 CACNA1G IL1R1

5.89e-04160514Facebase_RNAseq_e9.5_Facial Mesenchyne_500_K3
CoexpressionAtlasMyeloid Cells, DC.103-11b+F4/80lo.Kd, CD45+ CD11c+ I-A/I-E+ CD11b+ F4/80lo, Kidney, avg-3

LIFR GRK3 MMP12

7.21e-0473513GSM854273_100
CoexpressionAtlaskidney_adult_CortVasc_Tie2_k-means-cluster#2_top-relative-expression-ranked_1000

S100A4 LIFR SLC44A2 CASP8 DYSF

7.74e-04302515gudmap_kidney_adult_CortVasc_Tie2_k2_1000
CoexpressionAtlaskidney_adult_GlomCapSys_Tie2_top-relative-expression-ranked_1000

S100A4 ANKRD44 LIFR SLC44A2 CASP8 IL1R1 DYSF CCDC141

8.95e-04852518gudmap_kidney_adult_GlomCapSys_Tie2_1000
CoexpressionAtlasFacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_2500_k-means-cluster#2

S100A4 ANKRD44 NIBAN1 CASP8 CACNA1G IL1R1 ANGPTL1

9.16e-04655517Facebase_RNAseq_e9.5_Olfactory Placode_2500_K2
CoexpressionAtlasB cells, B1a.PC, IgD+ IgM+ CD19+ CD43+ CD5+ CD45R+, Peritoneal Cavity, avg-3

S100A4 LIFR IKZF3 RBM47 ANGPTL1

1.07e-03325515GSM538222_500
CoexpressionAtlasFacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_500

S100A4 ANKRD44 NIBAN1 CACNA1G IL1R1 ANGPTL1

1.08e-03489516Facebase_RNAseq_e8.5_Paraxial Mesoderm_500
CoexpressionAtlasFacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#1

S100A4 ANKRD44 NIBAN1 CASP8 CACNA1G IL1R1 RBM47 ANGPTL1

1.09e-03878518Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_2500_K1
ToppCellAdult-Immune-T_lymphocyte-D122|Adult / Lineage, Cell type, age group and donor

ANKRD44 NIBAN1 IKZF3 SIDT1 CASP8 CYFIP2

6.59e-0818052606c371d0f0c5a7b234dd143e98800e19af95a8b5
ToppCellControl-T_cells|Control / group, cell type (main and fine annotations)

ANKRD44 NIBAN1 IKZF3 SIDT1 CASP8 CYFIP2

8.26e-08187526f4e8e0eba58da89b56587667555a5d4754e108c7
ToppCellChildren_(3_yrs)-Immune-T_lymphocyte-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor

ANKRD44 NIBAN1 IKZF3 SIDT1 CASP8 CYFIP2

8.80e-08189526df30478b288084a1bd48f660409dcc784040897c
ToppCellCOVID-19-T_cells-CD8+_T_cells|COVID-19 / group, cell type (main and fine annotations)

ANKRD44 NIBAN1 IKZF3 SIDT1 CASP8 CYFIP2

8.80e-081895262c018d6120f65f0b2704b483bc9da1c0984872e3
ToppCellChildren_(3_yrs)-Immune-T_lymphocyte-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor

ANKRD44 NIBAN1 IKZF3 SIDT1 CASP8 CYFIP2

1.03e-071945263d6f2d190dd50804afea299957cc44c2bb756134
ToppCellControl-Lymphoid|Control / Disease state, Lineage and Cell class

ANKRD44 NIBAN1 IKZF3 SIDT1 CASP8 CYFIP2

1.03e-07194526d5b124f15c953eeb7e8e990df44d7fa466f2b31f
ToppCellBronchial-NucSeq-Immune_Lymphocytic-T-T_CD8|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

ANKRD44 NIBAN1 IKZF3 SIDT1 CASP8 CYFIP2

1.23e-0720052602c4169a23e5aaa0d4bfc78b51ba19ce8157dc3e
ToppCellfacs-MAT-Fat-18m-Myeloid-macrophage|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

S100A4 GRK3 SLC13A3 MMP12 RBM47

1.50e-06167525c2952d8ba763374c5678b92825c8956fc3e3ecd2
ToppCellChildren_(3_yrs)-Immune-natural_killer_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor

ANKRD44 IKZF3 SIDT1 CASP8 CYFIP2

1.83e-0617452533d6b81f31bfcb9c4b30206d88e20b9a94fba4a2
ToppCellControl-Lymphoid-T_Regulatory|World / Disease state, Lineage and Cell class

NIBAN1 IKZF3 CASP8 IL1R1 CCDC141

2.16e-0618052547036eee4c128fbb443d1fc767b4de5cced93f0e
ToppCellCOVID-19-T_cells-Tregs|COVID-19 / group, cell type (main and fine annotations)

ANKRD44 NIBAN1 IKZF3 CCDC141 CYFIP2

2.22e-06181525534659cf754326c6a73c0daa30e9d610612a0292
ToppCellControl-T_cells-CD8+_T_cells|Control / group, cell type (main and fine annotations)

ANKRD44 NIBAN1 IKZF3 SIDT1 CYFIP2

2.47e-0618552502ab64c0166c0646d1d4c6ed110ef0b75a1096d0
ToppCellCOVID-19-lung-B_cells|COVID-19 / Disease (COVID-19 only), tissue and cell type

ANKRD44 IKZF3 GRK3 SIDT1 CYFIP2

2.47e-06185525e8f1ad580f19705b5ca1d7d8867b2125f4891684
ToppCellChildren_(3_yrs)-Immune-B_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor

ANKRD44 IKZF3 SIDT1 ANGPTL1 CYFIP2

2.54e-06186525aa576748921a318798b911a611f05319b95e8d5e
ToppCellImmune-B_cell|World / Lineage, Cell type, age group and donor

ANKRD44 IKZF3 SIDT1 ANGPTL1 CYFIP2

2.61e-06187525795690c6306c366e733279491138d0cd9b469b21
ToppCell5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

ANKRD44 IKZF3 SIDT1 CASP8 CYFIP2

2.82e-06190525d153a0bdedcd6865e6ee19575234a78b5d859ff1
ToppCellControl-T_cells-CD4+_T_cells|Control / group, cell type (main and fine annotations)

ANKRD44 NIBAN1 IKZF3 CASP8 CYFIP2

2.82e-061905250733be5e54fe15d6d6ea51c154a95258e83f1b92
ToppCellCOVID-19-T_cells|COVID-19 / group, cell type (main and fine annotations)

ANKRD44 NIBAN1 IKZF3 SIDT1 CYFIP2

2.89e-061915257f64add931b64b8d35836fa6bee9ebab593844d3
ToppCellIPF-Lymphoid|IPF / Disease state, Lineage and Cell class

ANKRD44 NIBAN1 IKZF3 SIDT1 CYFIP2

3.04e-06193525bf9d50aea909a28dd1d0933af33842d5f1ae7818
ToppCellCOVID-19-lung-CD8+_T_cells|lung / Disease (COVID-19 only), tissue and cell type

ANKRD44 NIBAN1 IKZF3 SIDT1 CYFIP2

3.04e-06193525780e23e2705fc5c1b70e37568b79731ced5038bd
ToppCellChildren_(3_yrs)-Immune-T_lymphocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor

ANKRD44 NIBAN1 IKZF3 SIDT1 CYFIP2

3.04e-06193525b9769b45125d2244afe53f9f71c92c04ddccf980
ToppCellAdult-Immune-T_lymphocyte-D231|Adult / Lineage, Cell type, age group and donor

ANKRD44 NIBAN1 IKZF3 SIDT1 CYFIP2

3.12e-061945255c1dca33f382f37a7deb23e573578343c3b54986
ToppCellcellseq2-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

S100A4 ANKRD44 IKZF3 CASP8 CYFIP2

3.45e-0619852567e297b3f305d136ff586f68b618e25c902dbcb7
ToppCellcellseq2-Immune-Lymphocytic_T/NK|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

S100A4 ANKRD44 IKZF3 CASP8 CYFIP2

3.45e-06198525cb177bad587de804f98b38502a284dc267e37aff
ToppCellBronchial-NucSeq-Immune_Lymphocytic-T-T_CD4-T_reg|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

ANKRD44 IKZF3 SIDT1 CASP8 CYFIP2

3.45e-061985257608f67959e1cda7b10e57fd3af2f96216ebe7e9
ToppCellBronchial-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8_TRM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

ANKRD44 NIBAN1 IKZF3 CASP8 CYFIP2

3.62e-06200525be9a43acc2f926b9433ab3f018b911b03896a924
ToppCellBronchial-NucSeq-Immune_Lymphocytic-T|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

ANKRD44 NIBAN1 IKZF3 CASP8 CYFIP2

3.62e-06200525c6c2b39359c65c9444987d02d1c899dff2ad1366
ToppCelldroplet-Fat-SCAT-30m-Myeloid-monocyte|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

S100A4 NIBAN1 SUGP2 GRAMD4

3.07e-051535242731c3d4ac40ecc22108f8f3f45a069077159125
ToppCellE18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

S100A4 NIBAN1 IKZF3 SIDT1

3.65e-051605244a0ae0a83a10dbfc13591f4d2228ba8bcd2c2275
ToppCelldroplet-Limb_Muscle-nan-18m-Myeloid-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

S100A4 SLC13A3 CACNA1G RBM47

3.83e-0516252471d7849108a1b59beff40e46000172c45a2f5439
ToppCellfacs-Marrow-T_cells-18m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

IKZF3 LINGO1 CACNA1G GRK1

3.83e-0516252422f1abd20f43bc7e7fc46969da9962faf70ae5d2
ToppCellfacs-Marrow-T_cells-18m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

IKZF3 LINGO1 CACNA1G GRK1

3.83e-05162524966df4558140c3d541999ab553f201ae76a1c401
ToppCellClub-club-13|World / Class top

LARP4B MGST1 SIDT1 RBM47

3.83e-051625247d18f05a65ac715e62d610df9cc4a26539340dee
ToppCellcellseq-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK-ILC|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

IKZF3 SIDT1 CASP8 CYFIP2

3.83e-05162524553f91eaba72bcffb733ede45418bbee39c653ab
ToppCellfacs-Lung-EPCAM-24m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

S100A4 GRK3 CYFIP2 GRK1

4.02e-0516452415d52666e5150e7c34b1f641a937fb2d5e8aaf8a
ToppCellfacs-Lung-EPCAM-24m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

S100A4 GRK3 CYFIP2 GRK1

4.02e-05164524d622f0d8d8bad48dfdf160ec63c545df192637a9
ToppCellfacs-Lung-EPCAM-3m-Myeloid-Myeloid_Dendritic_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

S100A4 NIBAN1 GRK3 MMP12

4.12e-051655242477b0f1a0ea26184cf3cc4a9ffcdfa825cbc615
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic-Classical_Dendritic_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

ANKRD44 NIBAN1 GRK3 DYSF

4.21e-0516652463dc58864268b4e7779e4c45155022556fc634f9
ToppCellControl-B_cells-Activated_B_cells|Control / group, cell type (main and fine annotations)

ANKRD44 IKZF3 ANGPTL1 CYFIP2

4.42e-05168524a7159a35fe37f8c241cf8d391debe271e0698105
ToppCelldroplet-Liver-LIVER_NPC-30m-Lymphocytic-NK_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

S100A4 ANKRD44 IKZF3 CYFIP2

4.42e-05168524110c3c7c322e04a684a19c2b5434a502279fd000
ToppCellfacs-Lung-24m-Hematologic-myeloid-non-classical_monocyte|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

S100A4 GRK3 SLC44A2 CYFIP2

4.42e-05168524c861f80aa12caf54a94d93e38539ff41dc5227a6
ToppCelldroplet-Liver-LIVER_NPC-30m-Lymphocytic-NK/T|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

S100A4 ANKRD44 IKZF3 CYFIP2

4.42e-05168524735d30cfda1889740bdeb43e39330a52e8f4d599
ToppCellChildren_(3_yrs)-Immune-B_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor

ANKRD44 IKZF3 SIDT1 ANGPTL1

4.62e-05170524e421f9eedf74baffda1d03707a710ece4b777f29
ToppCellCOVID-19-kidney-Bcells|COVID-19 / Disease (COVID-19 only), tissue and cell type

ANKRD44 IKZF3 GRK3 SIDT1

4.73e-051715248e8fb79968b1a5c34d1d9cad7f9155fabfdb7cc7
ToppCelldroplet-Marrow-nan-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

S100A4 GRK3 SYT14 IL1R1

4.95e-051735246d2ceba4f89a228600e2b40aba81bb0eb81578c0
ToppCellLV-17._Lymphocyte|World / Chamber and Cluster_Paper

ANKRD44 IKZF3 SIDT1 CASP8

4.95e-05173524212f013ff761cbab24a537071739867c08c402a4
ToppCellCF-Myeloid-Neutrophil|Myeloid / Disease state, Lineage and Cell class

NIBAN1 IL1R1 DYSF CYFIP2

5.18e-051755248020c3a34f77e68e8149f87481fb1dddd2ac675e
ToppCellControl-B_cells-B_cells|Control / group, cell type (main and fine annotations)

ANKRD44 IKZF3 ANGPTL1 CYFIP2

5.29e-05176524d2c353783bd78dc24f28e00d917b88d8294fb5df
ToppCellCOVID-19-lung-B_cells|lung / Disease (COVID-19 only), tissue and cell type

ANKRD44 IKZF3 SIDT1 CYFIP2

5.41e-05177524f54691e5558091c1734ab15153a10bff15ed171e
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-B_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

ANKRD44 IKZF3 SIDT1 ANGPTL1

5.41e-05177524b07e6139618d888a9fd7cf43cad0d86a3f63e09e
ToppCellCOVID-19-B_cells-Activated_B_cells|COVID-19 / group, cell type (main and fine annotations)

ANKRD44 IKZF3 ANGPTL1 CYFIP2

5.41e-05177524653bb62a3744d4024ab3186ee01d410ed62832a6
ToppCellfacs-Heart-RA-18m-Lymphocytic-T_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

S100A4 IKZF3 SIDT1 CYFIP2

5.41e-0517752431201a72b7c1bdb0eff892b7072a35c80fd34727
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-B_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

ANKRD44 IKZF3 SIDT1 ANGPTL1

5.41e-051775246376ec12322c04d5d37ec2fdc376700464cbc7fb
ToppCellfacs-Heart-RA-18m-Lymphocytic-T_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

S100A4 IKZF3 SIDT1 CYFIP2

5.41e-0517752489d0131320cd96af8b0ee54f0f4d4771d17ef44e
ToppCellfacs-Heart-LA-18m-Lymphocytic|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

S100A4 IKZF3 SIDT1 CYFIP2

5.53e-05178524b4b4e021e86d1d523fa40695cb0a91021dee27d1
ToppCellfacs-Heart-LA-18m-Lymphocytic-T_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

S100A4 IKZF3 SIDT1 CYFIP2

5.53e-05178524d32b4e9c3d1f246ad49e2d8f6497989af68a6c00
ToppCellChildren_(3_yrs)|World / Lineage, Cell type, age group and donor

S100A4 ANKRD44 NIBAN1 CCDC141

5.53e-05178524df2ecd3214590b914f2762db57efe780ba038db3
ToppCellfacs-Heart-LA-18m-Lymphocytic-T_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

S100A4 IKZF3 SIDT1 CYFIP2

5.53e-05178524b7abf5656233e1a9cdbbe978dfa84d16f14b0be0
ToppCellChildren_(3_yrs)-Immune-B_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor

ANKRD44 IKZF3 SLC44A2 CYFIP2

5.77e-0518052440a12eb852373ae3d7c8d9bca376b0ae99f724b3
ToppCellfacs-Heart-RA-18m-Lymphocytic|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

S100A4 IKZF3 SIDT1 CYFIP2

5.77e-051805249be0af61d496a29d737bb772ad09864797994299
ToppCellIPF-Lymphoid-B|World / Disease state, Lineage and Cell class

ANKRD44 IKZF3 SIDT1 CYFIP2

5.77e-0518052430f9398c9b784f49470847a025bac90687e997a1
ToppCellCOVID-19-kidney-Bcells|kidney / Disease (COVID-19 only), tissue and cell type

ANKRD44 IKZF3 GRK3 SIDT1

5.77e-051805245650fc7ebcdf5e0be9a217a58d36a8386d59fd1b
ToppCellCOPD-Lymphoid-T_Regulatory|World / Disease state, Lineage and Cell class

NIBAN1 IKZF3 CASP8 CCDC141

5.77e-0518052451a12fbad5fa7bb12e6d616a02ff9b5141e2b063
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_B|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

ANKRD44 IKZF3 GRK3 SIDT1

5.77e-0518052465c069585737302a69b9a01476f4eb8b50cb2bfd
ToppCellCOVID-19-kidney-NK|COVID-19 / Disease (COVID-19 only), tissue and cell type

ANKRD44 IKZF3 SIDT1 CYFIP2

5.90e-051815248906ee8a7a1616dfe8c3b5c73988416641213629
ToppCell5'-Adult-LargeIntestine-Hematopoietic-T_cells-Treg|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

S100A4 ANKRD44 IKZF3 CCDC141

5.90e-05181524a6c8b33a392de3df2f179317e329e45d3d8c6f52
ToppCellLV-17._Lymphocyte|LV / Chamber and Cluster_Paper

ANKRD44 IKZF3 SIDT1 CASP8

5.90e-0518152481fafa69c8c240250a667a5f3b321e8be1b9a288
ToppCellnucseq-Immune-Lymphocytic_B-Lymphocytic_B-B|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

ANKRD44 IKZF3 SIDT1 CYFIP2

5.90e-051815248d8cc4dae2c8bd5f4b1c159f2a52edc4c9449c86
ToppCellmetastatic_Lymph_Node-Myeloid_cells-pDCs|Myeloid_cells / Location, Cell class and cell subclass

SIDT1 SLC44A2 NME8 CYFIP2

6.03e-0518252402e04294fce12591c32d7bd0e866a000ad1f836e
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-papillary_tips_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

SERPINB5 IKZF3 MGST1 SIDT1

6.03e-05182524678eadd57e7e830fc2bf9fd35616d3badce01705
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-papillary_tips_cell-Papillary_Tip_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

SERPINB5 IKZF3 MGST1 SIDT1

6.03e-051825248d1229fa5aa6e2e38f2ac6fe4f4dc89752fe9344
ToppCell3'-GW_trimst-1-SmallIntestine-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

NIBAN1 CASP10 IL1R1 DYSF

6.03e-05182524fc020d784ab81af80d9331cc322b7c259284eaef
ToppCellIPF-Lymphoid-B|IPF / Disease state, Lineage and Cell class

ANKRD44 IKZF3 SIDT1 CYFIP2

6.16e-05183524e37d2c015c34471a8a54a0299e94b0371e1ada5a
ToppCell10x5'v1-week_17-19-Myeloid_DC-DC-DC3|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

S100A4 NIBAN1 RBM47 PDIA3

6.16e-05183524c6cac433ea7a3d60728efdc7051e09e01bb3ade5
ToppCellCF-Myeloid-Neutrophil|CF / Disease state, Lineage and Cell class

NIBAN1 IL1R1 DYSF CYFIP2

6.16e-05183524da43827952e6fdee2ce94648c316182f272b321c
ToppCellControl-Lymphoid-B|Control / Disease state, Lineage and Cell class

ANKRD44 IKZF3 SIDT1 CYFIP2

6.29e-05184524de0294f879268bfd68e91adcc2adba211d221b7a
ToppCellPCW_10-12-Immune_Lymphocytic-Immune_Lymphocytic_NK/ILC-im_ILC2_(21)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung

S100A4 NIBAN1 IKZF3 CYFIP2

6.29e-0518452433db879e629821fb75684e60f8f0749cf9623bdd
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

ANKRD44 IKZF3 SIDT1 ANGPTL1

6.29e-05184524f81209e6bc01a0140f4487aa8b22eb02fbf0c39c
ToppCellCV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster

ANKRD44 IKZF3 PRKDC PDIA3

6.42e-05185524a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f
ToppCellnucseq-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK-Treg|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

NIBAN1 IKZF3 CASP8 IL1R1

6.42e-05185524a86a3a1a187a4d8d7762bc6d3dcb22c982178d22
ToppCellCOPD-Lymphoid-T_Regulatory|COPD / Disease state, Lineage and Cell class

NIBAN1 CASP8 IL1R1 CCDC141

6.42e-05185524846403edd4c8f646201d519055198fc38b7ffff9
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

ANKRD44 NIBAN1 IKZF3 SIDT1

6.42e-0518552445890fa81c65a48f4fdec164a4c8d0e2831243c0
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

ANKRD44 NIBAN1 IKZF3 SIDT1

6.42e-05185524585bcfdff85bf43f5aa4cd1b39f7dcf1c78d7b02
ToppCellControl-T_cells-NK_cells|Control / group, cell type (main and fine annotations)

ANKRD44 IKZF3 SIDT1 CYFIP2

6.42e-05185524755c0998c729f462399f1d5e88adf4bfae31be30
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

ANKRD44 NIBAN1 IKZF3 SIDT1

6.56e-051865249d576dce2c5deefef1adda16c6da7055c8d57f8f
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-T_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

ANKRD44 NIBAN1 IKZF3 SIDT1

6.56e-05186524bd3bd022b575d9b0ef90d50a5cb874085a827b77
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-T_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

ANKRD44 NIBAN1 IKZF3 SIDT1

6.56e-05186524924cc357b4c4ce8e9b05773bdab544f0b65474cc
ToppCellILEUM-inflamed-(1)_CD8_Trm|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

S100A4 NIBAN1 IKZF3 CASP8

6.69e-05187524a77d7ae44f47410bd92fb3aa0f44dce891752b63
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_B-B_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

ANKRD44 IKZF3 GRK3 SIDT1

6.69e-051875248fa454dc4e6a3e8e2bb2ad803acc579e0d3f76da
ToppCellSmart-seq2-blood_(Smart-seq2)-lymphocytic-B_lymphocytic-naive_B_cell|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

ANKRD44 GRK3 SLC44A2 ANGPTL1

6.69e-05187524160e5f338537d90d50f863a1be801b1071ac7da7
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_B-B_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

ANKRD44 IKZF3 GRK3 SIDT1

6.69e-05187524edad646d5eb1d70b768dc21fe02ef5265214e8e6
ToppCellVE-Treg-CD4_Treg|VE / Condition, Cell_class and T cell subcluster

S100A4 NIBAN1 IL1R1 CCDC141

6.83e-05188524fa88ceb336e30de3585e62608527a0d44df74190
ToppCellhuman_hepatoblastoma-NK.T_cells|World / Sample and Cell Type and Tumor Cluster (all cells)

ANKRD44 NIBAN1 IKZF3 SIDT1

6.83e-0518852471b7599e7e1d63cc0c8518c0501533755951d58f
ToppCellVE-Treg|VE / Condition, Cell_class and T cell subcluster

S100A4 NIBAN1 IL1R1 CCDC141

6.83e-05188524ef048517dfe2fc995d13eb1f08106a487354a4cc
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-T_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

ANKRD44 NIBAN1 IKZF3 CCDC141

6.98e-05189524b87d586a9570fa54f3e0c6bd4731c5badcaedae6
ToppCellfacs-Brain_Myeloid-Striatum-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LIFR SLC44A2 MTREX PDIA3

6.98e-051895246dd4ec5ce4beb856f0d2d1654e3c4676d1d63736
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

ANKRD44 NIBAN1 IKZF3 CCDC141

6.98e-05189524823d6debd09e440ddf36c54af24a5f20e222a21e
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-T_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

ANKRD44 NIBAN1 IKZF3 CCDC141

6.98e-0518952447c2b419b081d5bf75da5e3d9a0e05a70362dfe7
ToppCellfacs-Brain_Myeloid-Striatum-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LIFR SLC44A2 MTREX PDIA3

6.98e-051895243ae479ec7e00c57127cbe51a398329b10ca9848c
ToppCellfacs-Brain_Myeloid-Striatum-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LIFR SLC44A2 MTREX PDIA3

6.98e-05189524875df61ee48baa5142ba4d2427bdec1c53e5a828
DrugMetolazone [17560-51-9]; Down 200; 11uM; HL60; HG-U133A

TRAPPC11 LARP4B GRK3 GMEB1 CASP8 SMC5 NUP160

3.14e-071975272014_DN
DrugAC1NRC84

CASP8 CASP10 GRK1

1.83e-0611523CID005288871
Drug5140203; Down 200; 15uM; MCF7; HT_HG-U133A_EA

ZNF180 SIDT1 PKNOX1 SMC5 IL1R1 CYFIP2

5.36e-06195526908_DN
Drugwortmannin; Down 200; 0.01uM; SKMEL5; HG-U133A

TRAPPC11 GRK3 SUGP2 GMEB1 PKNOX1 NUP160

5.52e-06196526506_DN
DrugTolnaftate [2398-96-1]; Up 200; 13uM; HL60; HG-U133A

TRAPPC11 SUGP2 CASP10 SSR1 SMC5 NUP160

6.02e-061995262001_UP
Drugglycidamide

MGST1 SIDT1 CASP8 CASP10 IL1R1

1.18e-05130525ctd:C071834
Drugacrylonitrile

LINGO1 RTCA SPAG17 MPI

2.89e-0577524CID000007855
DrugAC1L1KC5

GRK3 RTCA CASP8 CASP10 CACNA1G GRM2 MMP12 PDIA3

2.89e-05541528CID000005428
DrugMometasone furoate [83919-23-7]; Up 200; 7.6uM; HL60; HG-U133A

OLAH PKNOX1 SSR1 IL1R1 NUP160

4.91e-051755251746_UP
DrugMipk

OLAH SPAG17

5.09e-055522CID000011251
DrugSalbutamol [18559-94-9]; Up 200; 16.8uM; PC3; HT_HG-U133A

SERPINB5 SIDT1 CASP8 CACNA1G IL1R1

5.92e-051825257376_UP
Drugd(GpG

PRKDC SSR1 MMP12

6.98e-0535523CID000161113
DrugPrecirol

MGST1 MMP12

7.63e-056522CID000114690
DrugTrichlorfon [52-68-6]; Down 200; 15.6uM; MCF7; HT_HG-U133A

LARP4B SUGP2 ZNF180 SIDT1 CYFIP2

8.01e-051945251675_DN
DrugOrlistat; Up 200; 10uM; MCF7; HT_HG-U133A

LIFR IKZF3 CASP10 GRM2 NME8

8.21e-051955256415_UP
Drugclofibrate; Down 200; 150uM; MCF7; HG-U133A

GRK3 ZNF180 CASP10 SMC5 NUP160

8.61e-05197525263_DN
DrugMafenide hydrochloride [138-37-4]; Up 200; 18uM; HL60; HG-U133A

GRK3 SUGP2 ANKMY1 SMC5 NUP160

8.61e-051975251441_UP
DrugAmprolium hydrochloride [137-88-2]; Down 200; 12.6uM; MCF7; HT_HG-U133A

GRK3 SUGP2 GMEB1 PKNOX1 CASP8

8.82e-051985251479_DN
DrugThiorphan [76721-89-6]; Down 200; 15.8uM; MCF7; HT_HG-U133A

LARP4B GRK3 SUGP2 PKNOX1 GRAMD4

9.03e-051995256249_DN
Drugsodium 4-phenylbutyrate; Up 200; 1000uM; MCF7; HG-U133A

CRYBB2 GRK3 SUGP2 GMEB1 DYSF

9.03e-05199525408_UP
DrugNorethindrone [68-22-4]; Down 200; 13.4uM; MCF7; HT_HG-U133A

CRYBB2 LARP4B GRK3 GMEB1 ANKMY1

9.25e-052005255474_DN
Drugfludrocortisone acetate; Down 200; 1uM; MCF7; HG-U133A

S100A4 ZNF562 ZNF180 CASP10 NUP160

9.25e-05200525282_DN
DrugEpirizole [18694-40-1]; Down 200; 17uM; MCF7; HT_HG-U133A

CRYBB2 SUGP2 ZNF180 SIDT1 PKNOX1

9.25e-052005251681_DN
Drugcobalt(II) chloride hexahydrate; Up 200; 100uM; MCF7; HG-U133A

SUGP2 GMEB1 SLC13A3 NUP160 MPI

9.25e-05200525383_UP
DiseaseAutoimmune lymphoproliferative syndrome

CASP8 CASP10

4.37e-056512cv:CN301239
DiseaseAutoimmune Lymphoproliferative Syndrome

CASP8 CASP10

8.15e-058512C1328840
DiseaseAutosomal recessive limb-girdle muscular dystrophy

TRAPPC11 DYSF

2.63e-0414512cv:C2931907
Diseaseesophagus adenocarcinoma (is_implicated_in)

CASP8 MMP12

6.02e-0421512DOID:4914 (is_implicated_in)
DiseaseLimb-girdle muscular dystrophy

TRAPPC11 DYSF

9.27e-0426512cv:C0686353
DiseaseSpinocerebellar Ataxia Type 2

SYT14 CACNA1G

1.59e-0334512C0752121
DiseaseSpinocerebellar Ataxia Type 1

SYT14 CACNA1G

1.59e-0334512C0752120
DiseaseSpinocerebellar Ataxia Type 5

SYT14 CACNA1G

1.59e-0334512C0752123
DiseaseSpinocerebellar Ataxia Type 7

SYT14 CACNA1G

1.59e-0334512C0752125
DiseaseSpinocerebellar Ataxia Type 6 (disorder)

SYT14 CACNA1G

1.59e-0334512C0752124
DiseaseAtaxia, Spinocerebellar

SYT14 CACNA1G

1.59e-0334512C0087012
DiseaseKeloid

S100A4 SERPINB5

1.68e-0335512C0022548
DiseaseSpinocerebellar Ataxia Type 4

SYT14 CACNA1G

1.68e-0335512C0752122

Protein segments in the cluster

PeptideGeneStartEntry
QKIGFLLFKDFCLNE

GRK3

61

P35626
NCKGEQFVFEKGEYP

CRYBB2

66

P43320
KCPENFNEAKFIGFT

GRM2

751

Q14416
GIKFFLIDFIFKRCP

GRAMD4

366

Q6IC98
FINEGPFKDCQQAKE

ANGPTL1

271

O95841
FGQFNPGCVERVKKI

RBM47

266

A0AV96
FGFPNFVKKIDAAVF

MMP12

371

P39900
FPFKDKLVVECFSQL

MDN1

2806

Q9NU22
FTELAQKGFCLPKEF

MDN1

4646

Q9NU22
ELSKQFVCFFKPAPE

GPR61

351

Q9BZJ8
FCELFKDIGRFVKDP

KIAA0895

401

Q8NCT3
FVCPGINVKCVKFND

GMEB1

111

Q9Y692
RKVFANPEDCVAFGK

MGST1

41

P10620
FKGDNLPKFINCEFA

LARP4B

256

Q92615
CATPEFVQGKEFKDF

LINGO1

396

Q96FE5
FVQGKEFKDFPDVLL

LINGO1

401

Q96FE5
LLEQKCFRKFIGNPF

ANKRD44

791

Q8N8A2
EILCQLKGNFPFKIV

PCDHGB3

381

Q9Y5G1
DKFFKQLQVVPLFGD

CYFIP2

296

Q96F07
VKDTFNGNLPFLFKV

MPI

86

P34949
LTDFIEKFKCEGPNV

CCDC141

191

Q6ZP82
VQLFKGKFFVCQGED

CACNA1G

1431

O43497
LDVKEQGQIPFFKFC

ANKMY1

866

Q9P2S6
KPKVFFIQACQGDNY

CASP8

351

Q14790
EKPKLFFIQACQGEE

CASP10

391

Q92851
KQFCVPGFKNNKGVA

SLC44A2

136

Q8IWA5
PEFFFAVVACGVKEK

DHRS7C

291

A6NNS2
VCLEQPIGKKLFQQF

GRK1

61

Q15835
PQKFIGEKRHCFDVN

IKZF3

271

Q9UKT9
GPIKFAEQAVFILFC

SLC13A3

336

Q8WWT9
FAEAKEFVKQCSPII

OLAH

166

Q9NV23
FGFESNKKNLVDPFV

DYSF

406

O75923
FVFKVLPEVLEKQCG

IL1R1

406

P14778
PGNFAKINFLCEIEI

LIFR

456

P42702
INKKFCFENVGGFPD

SYT14

46

Q8NB59
KGEDFPANNIVKFLV

SSR1

91

P43307
FVRKQEKEGKPFFCE

PKNOX1

96

P55347
KIKKFIQENIFGICP

PDIA3

231

P30101
CNEFFEGFPDKQPRK

S100A4

86

P26447
FKQLCEKEPLGNVLF

SERPINB5

16

P36952
PVFEGLAFKCIKLQF

NUP160

1241

Q12769
KNVGVDFCRFKVKQP

SPAG17

2101

Q6Q759
IGQELSKFNPCGKVF

ZNF562

171

Q6V9R5
TKCPEVFQGVEKLVF

ZBTB12

336

Q9Y330
VQDFVPFVQCKAKFH

TRAPPC11

581

Q7Z392
KCEPVFLFSVNGKII

NME8

81

Q8N427
FQPVIIFSFSKKDCE

MTREX

386

P42285
CKPELQKYEQFIFAD

NIBAN1

516

Q9BZQ8
ITLQKKDFPGEQFFV

SIDT1

246

Q9NXL6
KPIVEKFGFIFNCDI

RTCA

141

O00442
AVKTKNCFFEIIKPF

SUGP2

411

Q8IX01
IECGKAFVQKPEFII

ZNF585A

161

Q6P3V2
KPKDFSAFINLVEFC

PRKDC

616

P78527
FDFKECGQVLNPKIS

ZNF180

301

Q9UJW8
CQFLPQDKVGEFAKL

SMC5

176

Q8IY18